葉酸 Folate × 同半胱胺酸過高

結論:證據支持但有警示

The claim under evaluation is that folic acid lowers the homocysteine biomarker itself, and on that narrowly-framed claim the evidence is exceptionally strong.

A 🔵 A 中度證據 附警語發布 low — community discussion mostly non-commercial
⚠️ 標記 🧪 反證據已標記 🇹🇼 台灣在地警示 💊 檢驗 / 藥物交互作用

The claim under evaluation is that folic acid lowers the homocysteine biomarker itself, and on that narrowly-framed claim the evidence is exceptionally strong. The Homocysteine Lowering Trialists' Collaboration meta-analysis (PMID 11339443) shows folic acid alone reduces homocysteine ~25% and ~28-32% with B12, and the large SEARCH RCT (n=12,064) directly measured a 3.8 micromol/L (28%) reduction; Examine grades the homocysteine outcome A under Type 2 Diabetes and B under High Blood Pressure, EFSA authorises an Article 13(1) function claim for normal homocysteine metabolism, and Mayo, Cleveland Clinic and Harvard all confirm folate lowers the marker. This is a consistent, large, biologically-grounded surrogate effect, so an independent grade of A for the marker-lowering claim is warranted. The decisive caveat — central to any publication — is the surrogate-versus-hard-outcome gap: SEARCH, HOPE-2 and the NORVIT/VITATOPS family show that lowering homocysteine does NOT reduce myocardial infarction, coronary death or cardiovascular mortality (only a modest ~10% stroke signal), and the AHA does not treat homocysteine as an established cardiovascular risk factor. If the claim were instead framed as 'homocysteine-lowering improves clinical outcomes' the grade would collapse to C/D; the A grade applies strictly to the biomarker-lowering claim.

⚖️

評分透明度

所有分數由 7 層證據引擎計算,過程公開可查
原始分數 0.71
D
C
B
A
S
← 反證據 / 無效有效 / 強證據 →
最終評級
A · 附警語發布
信心度
86%
證據方向一致性高
證據層級
E2
多篇高品質統合分析(≥2 篇一致)

各層「支持此療效」的程度

分數越低=該層越不支持
L3 機轉生理合理性
0.65
L2 PubMed原始文獻
0.70
L5 臨床機構權威立場
0.70
L11 AI 複核獨立判讀
0.80
L1 Examine國際基準
0.85
不支持 中性 / 混合 支持
查看完整決策路徑(audit trail)
  1. compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.712
  2. tier_from_score — 依分數區間映射至 tier letter
  3. apply_hec_rules — 高品質 SR/MA 顯示 positive (1 篇 > 0 negative)
  4. tier_strict_requirement_check — Tier 條件達標,未降階
  5. detect_disputes — 偵測到 0 個 hard + 0 個 soft dispute
  6. decide_status — 依 tier + dispute 結果決定 status

Lowering blood homocysteine with folic acid-based supplements: meta-analysis of randomised trials (Homocysteine Lowering Trialists' Collaboration)
PMID: 11339443 2000 統合分析 n = 1,114
結論:Folic acid alone reduced blood homocysteine by ~25% (95% CI 23-28%); adding vitamin B12 (~0.5 mg/day) produced a further ~7% reduction; vitamin B6 produced no significant additional reduction. In typical Western populations daily folic acid plus B12 lowers homocysteine roughly a quarter to a third (e.g. from ~12 to 8-9 micromol/L).
🟢 高品質 效應量:Homocysteine -25% with folic acid; -32% with folic acid + B12
前往 PubMed
Effects of homocysteine-lowering with folic acid plus vitamin B12 vs placebo on mortality and major morbidity in myocardial infarction survivors: a randomized trial (SEARCH)
PMID: 20571015 2010 隨機對照試驗 n = 12,064
結論:Allocation to folic acid plus B12 reduced blood homocysteine by a mean of 3.8 micromol/L (28%), but did NOT reduce major vascular events (25.5% vs 24.8%; RR 1.04, 95% CI 0.97-1.12) or any vascular outcome; no adverse effect on cancer incidence.
🟢 高品質 政府資助 效應量:Homocysteine -3.8 micromol/L (-28%); major vascular events RR 1.04 (NS)
前往 PubMed
Homocysteine lowering with folic acid and B vitamins in vascular disease (HOPE-2)
PMID: 16531613 2006 隨機對照試驗 n = 5,522
結論:B-vitamin therapy lowered homocysteine but did NOT reduce the primary composite outcome (18.8% vs 19.8%; RR 0.95, 95% CI 0.84-1.07). Stroke alone was lower with vitamins (4.0% vs 5.3%; RR 0.75, 95% CI 0.59-0.97); hospitalizations for unstable angina were higher.
🟢 高品質 混合資助 效應量:Primary CV composite RR 0.95 (NS); stroke RR 0.75 (significant)
前往 PubMed
Folic Acid Supplementation and the Risk of Cardiovascular Diseases: A Meta-Analysis of Randomized Controlled Trials
PMID: 27528407 2016 統合分析 n = 82,334
結論:Folic acid supplementation produced a 10% lower risk of stroke (RR 0.90, 95% CI 0.84-0.96) and a 4% lower risk of overall CVD (RR 0.96, 95% CI 0.92-0.99), but NO significant effect on coronary heart disease (RR 1.04, 95% CI 0.99-1.09). Effects were stronger where baseline folate was low and where homocysteine reduction was larger.
效應量:Stroke RR 0.90; overall CVD RR 0.96; CHD RR 1.04 (NS)
前往 PubMed

L4a US FDA
支持
Health claims relating folate to risk of neural tube defects may be made on the label or in labeling of foods, including dietary supplements, provided that the requirements in this section are met. 來源↗
L4b EU EFSA
支持
L4c UK NHS
中性
It's recommended that all women who could get pregnant should take a 400 microgram folic acid supplement daily before pregnancy and until they're 12 weeks pregnant. 來源↗
L4d TW TFDA / 衛福部
支持
孕期缺乏葉酸,會增加胎兒腦及脊髓先天性神經管缺陷的風險。育齡婦女及準備懷孕婦女可在準備階段每日攝取400微克,懷孕期間每日攝取600微克。 來源↗
L4e WHO
中性
Current evidence suggests that folic acid supplementation in the periconceptional period, either alone or in combination with other vitamins and minerals, can prevent neural tube defects. 來源↗

L5a NIH Office of Dietary Supplements
支持
L5b Mayo Clinic
支持
Although taking folic acid reduces the level of homocysteine and provides protection against stroke, it doesn't appear to decrease deaths from heart attack or other cardiovascular causes. 來源↗
L5c Cleveland Clinic
支持
L5d Harvard Health
支持
L5e Specialty Society (condition-mapped)
謹慎

PTT · Dcard · Mobile01 彙整自公開論壇討論,非統計抽樣,僅反映社群風向。
廣告 / 業配密度 低度
📍立場總覽

台灣社群(PTT/Dcard/Mobile01)對「葉酸」的討論幾乎全部聚焦在備孕/孕期預防神經管缺陷與選品(活性葉酸 5-MTHF vs 一般葉酸),而非「同半胱胺酸過高」。僅 FITNESS/Health 板少數綜合 B 群討論順帶提及 B 群(含葉酸、B6、B12)參與同半胱胺酸代謝,但無人以「降同半胱胺酸」為目的實測補充葉酸並回報心得。此 condition 配對在社群屬冷門、近乎無真實討論。

💬社群實感

無共識(社群幾乎無以降同半胱胺酸為目的之葉酸實測心得;既有討論集中於備孕/孕期,與本 condition 不相干)

L10a · 廠商行銷話術 行銷語言
💬 通路如何宣傳

孕哺兒媽媽葉酸口嚼錠:60錠/盒,成分為葉酸400微克,每日補充1顆,價格約NT$499

代表來源 ↗
L10b · TFDA 法定身份 官方認定

懷孕婦女自懷孕前1個月至整個孕期,每日應攝取600微克葉酸,且不宜超過1000微克

來源 ↗

  • 葉酸(folic acid)治療
  • 維生素 B12 合併治療
PMID 100% 反查全部經 NCBI Entrez 驗證
🔬 4 篇 L2 文獻 經多層 sub-agent 獨立評估
🇹🇼 含台灣社群分析L10c PTT / Dcard / Mobile01
aggregated_at: 2026-06-01 claim_version: v31 engine_version: v1.0 claim_id: CLM-COND-homocysteine-INT-folate-001
查看 ClaimReview 結構化資料 (JSON-LD)
{
  "@context": "https://schema.org",
  "@type": "ClaimReview",
  "url": "https://gpt-dict.com/claim/CLM-COND-homocysteine-INT-folate-001/",
  "datePublished": "2026-06-01",
  "author": {
    "@type": "Organization",
    "name": "gpt-dict.com",
    "url": "https://gpt-dict.com"
  },
  "claimReviewed": "葉酸能改善同半胱胺酸過高",
  "inLanguage": "zh-TW",
  "itemReviewed": {
    "@type": "Claim",
    "appearance": []
  },
  "reviewRating": {
    "@type": "Rating",
    "ratingValue": 4,
    "bestRating": 5,
    "worstRating": 1,
    "alternateName": "🔵 A 中度證據"
  }
}